Author: Rahul Sharma

In extensive-stage small-cell lung cancer (ES-SCLC), IMpower133 improved progression-free survival...

Researchers conducted the MATCH study to assess the clinical benefits of adding low-dose...

According to IMpower133 and CASPIAN, anti-PD-L1 blockades combined with etoposide and platinum...

Researchers studied neoadjuvant immunotherapy to produce a pathologic response in patients with...

Merkel Cell Carcinoma (MCC) was rare, and aggressive skin cancer became more common as the...